MX2024005608A - Lipido cationico. - Google Patents

Lipido cationico.

Info

Publication number
MX2024005608A
MX2024005608A MX2024005608A MX2024005608A MX2024005608A MX 2024005608 A MX2024005608 A MX 2024005608A MX 2024005608 A MX2024005608 A MX 2024005608A MX 2024005608 A MX2024005608 A MX 2024005608A MX 2024005608 A MX2024005608 A MX 2024005608A
Authority
MX
Mexico
Prior art keywords
sup
sub
possibly substituted
group
alkyl group
Prior art date
Application number
MX2024005608A
Other languages
English (en)
Spanish (es)
Inventor
Yasutaka Hoashi
Satoru Matsumoto
Yoshimasa Omori
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of MX2024005608A publication Critical patent/MX2024005608A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX2024005608A 2021-11-10 2022-11-09 Lipido cationico. MX2024005608A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021183413 2021-11-10
PCT/JP2022/041651 WO2023085299A1 (ja) 2021-11-10 2022-11-09 カチオン性脂質

Publications (1)

Publication Number Publication Date
MX2024005608A true MX2024005608A (es) 2024-05-22

Family

ID=86335736

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024005608A MX2024005608A (es) 2021-11-10 2022-11-09 Lipido cationico.

Country Status (13)

Country Link
US (1) US20250197343A1 (https=)
EP (1) EP4431489A4 (https=)
JP (1) JPWO2023085299A1 (https=)
KR (1) KR20240109991A (https=)
CN (1) CN118201905A (https=)
AR (1) AR127615A1 (https=)
AU (1) AU2022388185A1 (https=)
CA (1) CA3237659A1 (https=)
CO (1) CO2024005797A2 (https=)
IL (1) IL312605A (https=)
MX (1) MX2024005608A (https=)
TW (1) TW202340137A (https=)
WO (1) WO2023085299A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043390A (en) * 1998-04-03 2000-03-28 The Regents Of The University Of California Pentaerythritol lipid derivatives and nucleic-acid complexes
AU2003240978A1 (en) 2002-05-31 2003-12-19 Genteric, Inc. Multi-functional polyamines for delivery of biologically-active polynucleotides
US8729257B2 (en) * 2009-07-17 2014-05-20 Harbin Institute Of Technology Hybrid lipid compounds based on pentaerythritol, intermediates, preparation methods and use thereof
JP6333604B2 (ja) * 2013-07-09 2018-05-30 富士フイルム株式会社 着色組成物、硬化膜、カラーフィルタ、カラーフィルタの製造方法、固体撮像素子、および画像表示装置
WO2016021683A1 (ja) 2014-08-07 2016-02-11 武田薬品工業株式会社 カチオン性脂質
TWI802627B (zh) 2017-12-28 2023-05-21 日商武田藥品工業股份有限公司 陽離子性脂質
DK3835287T3 (da) 2018-08-10 2025-01-02 Takeda Pharmaceuticals Co Kationisk lipid

Also Published As

Publication number Publication date
JPWO2023085299A1 (https=) 2023-05-19
TW202340137A (zh) 2023-10-16
KR20240109991A (ko) 2024-07-12
CN118201905A (zh) 2024-06-14
EP4431489A4 (en) 2025-11-12
CO2024005797A2 (es) 2024-05-10
EP4431489A1 (en) 2024-09-18
IL312605A (en) 2024-07-01
AR127615A1 (es) 2024-02-14
US20250197343A1 (en) 2025-06-19
CA3237659A1 (en) 2023-05-19
AU2022388185A1 (en) 2024-05-23
WO2023085299A1 (ja) 2023-05-19

Similar Documents

Publication Publication Date Title
TW365602B (en) New farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions which contain them
RU2012107446A (ru) Устойчивые к гидролизу фосфитные композиции
AU649849B2 (en) New vanadium complexes, process for preparing them and pharmaceutical compositions containing them
RU2016101795A (ru) Химические составы, отверждающиеся посредством присоединения по михаэлю, в случае композиций серосодержащих полимеров с использованием бис(сульфонил)алканолов
BR9611692A (pt) Agentes de limpeza para superfícies duras
ATE46354T1 (de) Trisorganophosphitzusammensetzungen mit hydrolytischer stabilitaet.
MY201883A (en) Quaternary ammonium compound and fuel composition
MX2024005608A (es) Lipido cationico.
GB1014887A (en) Shampoos
KR900004258A (ko) 장쇄질소염기와 제초성산의 염
ID28204A (id) Formulasi perawatan pembersih pribadi yang mengandung senyawa amonium keempat dan senyawa mengandung nitrogen lainnya
PH20913A (en) Mathylenediphosphonic acid derivatives and antirheumatic pharmaceutical compositions containing them
BR9916254B1 (pt) processo para a preparação de alquileno glicóis.
NO20022044D0 (no) 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasöytiske preparater derav og deres anvendelse som antikonvulsive midler
MX2022009047A (es) Insecticidas mesoionicos.
GB1089429A (en) Novel phosphonates containing acetal and ketal groups
MX2026000978A (es) Retardante de llama derivado de dopo que contiene a-hidroxilo y que tiene una estructura ciclica como cadena de puente, metodo de preparacion y uso del mismo
ATE13765T1 (de) 2-(1,4-benzodioxan-2-ylalkyl)-imidazole, deren herstellung und sie enthaltende pharmazeutische mittel.
KR920009956A (ko) 석탄-물 슬러리용 첨가제 및 석탄-물 슬러리 조성물
ES8700014A1 (es) Procedimiento de obtencion de composiciones para prolongar la accion de herbicidas conteniendo tiolcarbamatos como in- gredientes activos
TNSN08162A1 (en) Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
GB1480019A (en) Hydroxyaliphatic esters of n-phosphonomethyl glycine and their use as herbicides
ATE393807T1 (de) Alkylbernsteinsäurehydrazid-additive für schmiermittel
DE60215158D1 (de) Pumpfähige, flüssige, grenzflächenaktive mittel enthaltende zusammensetzungen, umfassend alkanolaminsalze von alkylphosphatestern
AR132919A1 (es) Insecticidas de pirazolamida